TOCOX-a randomised, double-blind, placebo-controlled trial of rofecoxib (a COX-2-specific prostaglandin inhibitor) for the prevention of preterm delivery in women at high risk
収録刊行物
-
- BJOG
-
BJOG 112 725-730, 2005